Disclosures for "BHV-2100, a First-in-class TRPM3 Antagonist for the Treatment of Pain"
-
Prof. Vriens has nothing to disclose.
-
Dr. Vanherck has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. MARCHAND has received intellectual property interests from a discovery or technology relating to health care. Dr. MARCHAND has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Fonds Wetenschappelijk Onderzoek.
-
Dr. Car has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Car has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PathAI. Dr. Car has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Biohaven. Dr. Car has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Agios Pharmaceuticals. Dr. Car has stock in biohaven. Dr. Car has stock in Agios.
-
Gene Dubowchik has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gene Dubowchik has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Morrison & Foerster LLP. Gene Dubowchik has stock in Biohaven Pharmaceuticals.
-
Mr. Caldwell has received personal compensation for serving as an employee of Biohaven. Mr. Caldwell has stock in Biohaven.
-
Dr. Granit has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Granit has stock in Biohaven. Dr. Granit has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Member with University of Miami. Dr. Granit has a non-compensated relationship as a collaborator in clinical trial design with Cartesian Therapeutics that is relevant to AAN interests or activities.
-
Mr. Marcin has received personal compensation for serving as an employee of Biohaven. An immediate family member of Mr. Marcin has received personal compensation for serving as an employee of Takeda. Mr. Marcin has stock in Biohaven. An immediate family member of Mr. Marcin has stock in Takeda. An immediate family member of Mr. Marcin has stock in Bristol Myers Squibb.
-
Dr. Pirman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Pirman has received personal compensation for serving as an employee of Agios Pharmaceuticals. Dr. Pirman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scaffold Therapeutics. Dr. Pirman has stock in Biohaven. Dr. Pirman has stock in Agios.
-
Dr. Chaltin has stock in some biotech companies . Dr. Chaltin has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Prof. Voets has received research support from Biohaven .